Measuring Preparedness

Countermeasure
Management

National
Confidence Interval
5.9 - 6.6
National
Preparedness Level
6.2

What it Means

Actions to store and deploy medical and pharmaceutical products that prevent and treat the effects of hazardous substances and infectious diseases, including vaccines, prescription drugs, masks, gloves, and medical equipment.

How we Measure it

Countermeasure Management Sub-domains

mmmdd: medical materiel management distribution dispensing

cue: countermeasure utilization effectiveness

This is best viewed on desktop.

The ability to acquire, maintain (e.g., cold chain storage or other storage protocol), transport, distribute, and track medical materiel (e.g., pharmaceuticals, gloves, masks, and ventilators) before and during an incident and recover and account for unused medical materiel after an incident. This capability includes managing the research, development, and procurement of medical countermeasures in addition to the management and distribution of medical countermeasures.

Measure
Measure Description
Source
m60
State has developed a written countermeasure management plan including Strategic National Stockpile (SNS) elements.
Measure Name

M60

Measure Source

CDC PHEP

Data date(s)

2012-2018

Limitations

The measure does not evaluate whether the state has the resources and ability to implement the plan in a timely and effective manner.

m161
Number of Pharmacists per 100,000 population in the state.
Measure Name

M161

Measure Source

Bureau of Labor Statistics (BLS), Occupational Employment Statistics (OES)

Data date(s)

2012-2019

Limitations

The measure does not consider mutual aid plans that may be in place for health care facilities to supplement the number of available pharmacists in the event of an emergency. Also, BLS and other national data sources on health provider supply have been shown to undercount certain types of providers, and may differ considerably from the estimates available from state licensing boards. Since the measurement undercounting in the BLS data are expected to be relatively consistent across states, they should not cause significant bias in the Index state and national results. The Bureau of Labor Statistics (BLS) produces occupational estimates by surveying a sample of non-farm establishments. As such, estimates produced through the Occupational Employment Statistics (OES) program are subject to sampling error.

m270
Percent of hospitals in the state participating in a group purchasing arrangement.
Measure Name

M270

Measure Source

American Hospital Association (AHA), Annual Survey of Hospitals

Data date(s)

2012-2018

Limitations

Although group purchasing arrangements may be in place, many other economic and non-economic factors affect shortages of drugs and medical supplies and create gaps in the supply chain.

The level to which the community has achieved preparedness for vaccination and immunization and the level to which the community completes a course of countermeasure usage or follows through in the use of an intervention. This also covers the resultant outcome from the appropriate use of the intervention.

Measure
Measure Description
Source
m24
Percent of children ages 19-35 months in the state receiving the recommended routine childhood combined 7-vaccine series (4:3:1:3*:3:1:4), which includes ≥4 doses of DTaP, ≥3 doses of poliovirus vaccine, ≥1 dose of measles-containing vaccine, the full series of Hib (≥3 or ≥4 doses, depending on product type), ≥3 doses of HepB, ≥1 dose of varicella vaccine, and ≥4 doses of PCV.
Measure Name

M24

Measure Source

Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHC), National Immunization Survey (NIS)

Data date(s)

2012-2019

Limitations

The measure evaluates routine vaccines for preventable disease in pre-school age children, and may not reflect the vaccination rate for a severe emerging disease.

m32
Percent of seniors age 65 and older in the state receiving a seasonal flu vaccination.
Measure Name

M32

Measure Source

Centers for Disease Control and Prevention (CDC), National Immunization Survey (NIS) and the Behavioral Risk Surveillance System (BRFSS), FluVaxView State, Regional, and National Vaccination Report

Data date(s)

2013-2020

Limitations

Vaccine effectiveness varies each year as a function of the accuracy in predicting the influenza strains covered by each year's vaccine. As a result, expected influenza protection and reduced demand on health care facilities may be marginal in the event of a major disaster.

m33
Percent of seniors age 65 and older in the state receiving a pneumococcal vaccination.
Measure Name

M33

Measure Source

Centers for Disease Control and Prevention (CDC), Behavioral Risk Factor Surveillance System Survey Questionnaire (BRFSS). Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Survey data analyzed by PMO personnel.

Data date(s)

2012-2019

Limitations

The measure evaluates the recommended vaccine for preventable disease in seniors, and may not reflect the vaccination rate for a severe emerging disease.

m34
Percent of children aged 6 months to 4 years old in the state receiving a seasonal flu vaccination.
Measure Name

M34

Measure Source

Centers for Disease Control and Prevention (CDC), National Immunization Survey (NIS) and the Behavioral Risk Surveillance System (BRFSS), FluVaxView State, Regional, and National Vaccination Report

Data date(s)

2012-2020

Limitations

Vaccine effectiveness varies each year as a function of the accuracy in predicting the influenza strains covered by each year's vaccine. As a result, expected influenza protection and reduced demand on health care facilities may be marginal in the event of a major disaster.

m35
Percent of adults aged 18 years and older in the state receiving a seasonal flu vaccination.
Measure Name

M35

Measure Source

Centers for Disease Control and Prevention (CDC), National Immunization Survey (NIS) and the Behavioral Risk Surveillance System (BRFSS), FluVaxView State, Regional, and National Vaccination Report

Data date(s)

2013-2020

Limitations

Vaccine effectiveness varies each year as a function of the accuracy in predicting the influenza strains covered by each year's vaccine. As a result, expected influenza protection and reduced demand on health care facilities may be marginal in the event of a major disaster.